Angelini Pharma clinical trials

Also known as ACRAF.

Part of Angelini Holding S.p.A., which holds 100% as of 2024-12-31. Source

The registry lists 60 studies whose lead sponsor is Angelini Pharma or one of 3 companies grouped under it. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 24, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 60. Browse all 60 →

• Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMITRecruitingNCT06564974

  Sponsor listed in the registry: Catalyst Pharmaceuticals, Inc. · First submitted before Catalyst Pharmaceuticals, Inc. became part of Angelini Pharma

• Real-world Clinical Response to Trazodone in Italy, Poland, and RomaniaRecruitingNCT07377682

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource UtilizationRecruitingNCT06922175

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Real-world Clinical Response to Cenobamate Early add-on in France, Germany and SpainRecruitingNCT06716801

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• The Effectiveness of Heat Treatment on Knee Pain in Patients With Osteoarthritis - an International, Multicenter Clinical InvestigationRecruitingNCT06650631Not applicable

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Palatability Study of Five Formulations of Benzydamine HCl LozengesCompletedNCT07199543Phase 1

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Adjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) StudyActive, not recruitingNCT05867160

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Cenobamate in Adults With Focal-Onset SeizuresActive, not recruitingNCT05859854

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Bioavailability of Trazodone Hydrochloride (New Polymer) vs. Trazodone Hydrochloride Contramid® at Steady-state.CompletedNCT06773767Phase 1

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic SyndromeApproved for marketingNCT02189720

  Sponsor listed in the registry: Catalyst Pharmaceuticals, Inc. · First submitted before Catalyst Pharmaceuticals, Inc. became part of Angelini Pharma

• Different Dosage Regimens of Methocarbamol/Paracetamol in Acute Non-specific Low Back Pain. MioPain StudyTerminatedNCT05204667Phase 4

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Lurasidone Non-Interventional Study in Schizophrenia PatientsCompletedNCT06527885

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)TerminatedNCT03579966Phase 3

  Sponsor listed in the registry: Catalyst Pharmaceuticals, Inc. · First submitted before Catalyst Pharmaceuticals, Inc. became part of Angelini Pharma

• New Paediatric Formulation of Tachipirina®CompletedNCT06358586Not applicable

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• The Effectiveness of Sustained Heat Treatment on Delayed-Onset Muscle Soreness (DOMS)CompletedNCT06111118Not applicable

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MGCompletedNCT03304054Phase 3

  Sponsor listed in the registry: Catalyst Pharmaceuticals, Inc. · First submitted before Catalyst Pharmaceuticals, Inc. became part of Angelini Pharma

• This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UKCompletedNCT05747001

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3TerminatedNCT03819660Phase 2

  Sponsor listed in the registry: Catalyst Pharmaceuticals, Inc. · First submitted before Catalyst Pharmaceuticals, Inc. became part of Angelini Pharma

• First choIce Antidepressants: General Practitioner's Treatment Approach in the Czech RepublicTerminatedNCT05291897

  Sponsor listed in the registry: Angelini Pharma Česká republika s.r.o. · Angelini Pharma Česká republika s.r.o. — acquired company within the Angelini Pharma group

• Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"CompletedNCT04312503

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Efficacy of the Combination of Ibuprofen and Paracetamol in Acute Non-specific Low Back PainCompletedNCT05222724Phase 4

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Benzydamine Oromucosal Solution in Oral Mucositis (BOOM)CompletedNCT05055726Phase 4

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.TerminatedNCT04742413

  Sponsor listed in the registry: Angelini Farmacéutica

• Long-term Study With Trazodone Once-a-DayCompletedNCT04295941

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)CompletedNCT04959799

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Dalbavancin in Real Clinical Practice in SpainCompletedNCT04485676

  Sponsor listed in the registry: Angelini Farmacéutica

• Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSICompletedNCT04298463

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Bioavailability Study of 300 mg Trazodone Hydrochloride (New Polymer) vs. 300 mg Trazodone Hydrochloride (Contramid® Prolonged-release Tablets) Under Fasting ConditionsCompletedNCT05136521Phase 1

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Treatment of Breakthrough Cancer Pain According to European GuidelinesTerminatedNCT04468490

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Benzydamine in Sore Throat Pain Relief (BePaiR Study)CompletedNCT04941976Phase 4

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 PatientsCompletedNCT03781479Phase 2

  Sponsor listed in the registry: Catalyst Pharmaceuticals, Inc. · First submitted before Catalyst Pharmaceuticals, Inc. became part of Angelini Pharma

• Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic NeuropathyCompletedNCT03749642Phase 2

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Prulifloxacin in Chronic Bacterial Prostatitis (CBP)CompletedNCT03201796Phase 2

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• A Safety, Tolerability and Pharmacokinetic Study of CPP-115CompletedNCT01493596Phase 1

  Sponsor listed in the registry: Catalyst Pharmaceuticals, Inc. · First submitted before Catalyst Pharmaceuticals, Inc. became part of Angelini Pharma

• Amifampridine Phosphate for the Treatment of Congenital Myasthenic SyndromesCompletedNCT02562066Phase 3

  Sponsor listed in the registry: Catalyst Pharmaceuticals, Inc. · First submitted before Catalyst Pharmaceuticals, Inc. became part of Angelini Pharma

• Bioequivalence of Ketoprofen Oral Gel vs Ketoprofen Lysine Salt as Granules for Oral SolutionCompletedNCT04678076Phase 1

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Bioequivalence of Flurbiprofen Lozenge vs StrepfenCompletedNCT04670601Phase 1

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine DependenceTerminatedNCT00730522Phase 2

  Sponsor listed in the registry: Catalyst Pharmaceuticals, Inc. · First submitted before Catalyst Pharmaceuticals, Inc. became part of Angelini Pharma

• A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive PolymerCompletedNCT03706781Phase 1

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Effects of Three Single Oral Doses of Trazodone on the QTc Interval Duration in Healthy VolunteersCompletedNCT03516630Phase 1

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)CompletedNCT03435120

  Sponsor listed in the registry: Angelini Farmacéutica

• SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)TerminatedNCT03210480Phase 4

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COSStatus unknownNCT04122729

  Sponsor listed in the registry: Angelini Farmacéutica

• Paracetamol in Patent Ductus ArteriosusCompletedNCT02422966Phase 2

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)CompletedNCT02970162Phase 3

  Sponsor listed in the registry: Catalyst Pharmaceuticals, Inc. · First submitted before Catalyst Pharmaceuticals, Inc. became part of Angelini Pharma

• Trazodone in Painful Diabetic NeuropathyCompletedNCT03202979Phase 2

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care UnitsCompletedNCT02840500

  Sponsor listed in the registry: Angelini Farmacéutica

• Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative IntentCompletedNCT02836379

  Sponsor listed in the registry: Angelini Farmacéutica

• Tolerability and Pharmacokinetic Study of Econazole Nitrate and Benzydamine HCl Intravaginal CreamCompletedNCT02713893Phase 1

  Sponsor listed in the registry: Aziende Chimiche Riunite Angelini Francesco S.p.A

• A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)CompletedNCT01377922Phase 3

  Sponsor listed in the registry: Catalyst Pharmaceuticals, Inc. · First submitted before Catalyst Pharmaceuticals, Inc. became part of Angelini Pharma